The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Interdisciplinary collaboration is key to reducing the risk for osteonecrosis of the jaw and improving patient care.

A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.

The Osteoporosis Society of the Philippines Foundation Inc. (OSPFI) estimates that by 2050, around 10.2 million Filipinos ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...

Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...

Texas County Memorial Hospital’s radiology department now has a new Hologic Horizon DXA bone densitometer, an upgrade from ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...